<SEC-DOCUMENT>0001437749-25-019718.txt : 20250606
<SEC-HEADER>0001437749-25-019718.hdr.sgml : 20250606
<ACCEPTANCE-DATETIME>20250606160702
ACCESSION NUMBER:		0001437749-25-019718
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250605
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250606
DATE AS OF CHANGE:		20250606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOPHARMA, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38247
		FILM NUMBER:		251030642

	BUSINESS ADDRESS:	
		STREET 1:		7900 E. UNION AVENUE
		STREET 2:		SUITE 920
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		7900 E. UNION AVENUE
		STREET 2:		SUITE 920
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aytu20250523c_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:aytu="http://www.aytu.com/20250605"><head>
	<title>aytu20250523c_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 6/6/2025 7:45:52 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20258K" name="dei:AmendmentFlag" id="ixv-252">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20258K" name="dei:EntityCentralIndexKey" id="ixv-253">0001385818</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="aytu-20250605.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20258K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001385818</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-06-05</xbrli:startDate>
<xbrli:endDate>2025-06-05</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/>
<div style="font-family: Times New Roman; font-size: 14pt; font-variant: normal; text-align: center; margin: 0pt;"><b>UNITED STATES</b></div>

<div style="font-family: Times New Roman; font-size: 14pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></div>

<div style="font-family: Times New Roman; font-size: 14pt; font-variant: normal; text-align: center; margin: 0pt;"><b>FORM</b>&#160;<b><ix:nonNumeric contextRef="d20258K" name="dei:DocumentType" id="ixv-263">8-K</ix:nonNumeric></b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Pursuant to Section</b>&#160;<b>13 OR&#160;15(d) of The Securities Exchange Act of 1934</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-264">June 5, 2025</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<div style="text-align: center;">
<div><img alt="logo01.jpg" src="logo01.jpg"/></div>
</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityRegistrantName" id="ixv-265">AYTU BIOPHARMA, INC.</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-266">Delaware</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityFileNumber" id="ixv-267">001-38247</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityTaxIdentificationNumber" id="ixv-268">47-0883144</ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or other jurisdiction of incorporation)</div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File Number)</div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 32%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(IRS Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressAddressLine1" id="ixv-269">7900 East Union Avenue, Suite 920</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressCityOrTown" id="ixv-270">Denver</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressStateOrProvince" id="ixv-271">CO</ix:nonNumeric> <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressPostalZipCode" id="ixv-272">80237</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices, including zip code)</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20258K" name="dei:CityAreaCode" id="ixv-273">720</ix:nonNumeric>) <ix:nonNumeric contextRef="d20258K" name="dei:LocalPhoneNumber" id="ixv-274">437-6580</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Not applicable&#160;</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-275">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: Times New Roman; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-276">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: Times New Roman; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-277">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: Times New Roman; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-278">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: Times New Roman; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section&#160;12(b) of the Act:</div>

<div style="font-family: Times New Roman; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 39%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Title of Each Class</div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 18%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Trading Symbol(s)</div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 39%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of Each Exchange on Which Registered</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 39%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:Security12bTitle" id="ixv-279">Common Stock</ix:nonNumeric>, par value $0.0001 per share</b></div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 18%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:TradingSymbol" id="ixv-280">AYTU</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 39%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>The <ix:nonNumeric contextRef="d20258K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-281">Nasdaq</ix:nonNumeric>&#160;Capital Market</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: Times New Roman; font-size: 8pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-282">&#9744;</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. &#9744;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/>
<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Item 1.01&#160;Entry into a Material Definitive Agreement.</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">On June 5, 2025, Aytu BioPharma, Inc. (the &#8220;Company&#8221; or &#8220;Aytu&#8221;), entered into an Exclusive Commercialization Agreement (the &#8220;Agreement&#8221;) with Fabre-Kramer Holdings, Inc. (&#8220;Fabre-Kramer&#8221;), pursuant to which the Company acquired certain rights and obligations in connection with the commercialization of EXXUA&#8482; (gepirone) extended release tablets, an FDA-approved pharmaceutical indicated for the treatment of Major Depressive Disorder (MDD) in adults, in any formulation and any dosage strength for all current and future indications (the &#8220;Product&#8221;) at any time before or during the term of the Agreement in the United States of America, its commonwealths, territories, and possessions (the &#8220;Territory&#8221;). EXXUA is a first-in-class, FDA-approved treatment for MDD with a novel mechanism of action and differentiated clinical profile, and, upon the execution of the Agreement, the Company&#160;anticipates launching EXXUA in the fourth calendar quarter of 2025 through its commercial team. EXXUA has been extensively studied in over 5,000 patients and represents a new class of therapeutics to compete in the over $22&#160;billion United States prescription MDD market. It can become a very important treatment option for the over 21 million Americans affected by MDD. Over 340 million antidepressant prescriptions were written in 2024 in the United States, yet significant unmet needs remain considering the unacceptable side effects associated with current therapeutics.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">As consideration for the Agreement, the Company made an upfront cash payment of $3,000,000 to Fabre-Kramer on the effective date of the Agreement. Within forty-five (45) days of the one-year anniversary of the first physical sale of Product in the Territory through a bona fide, arm&#8217;s length transaction to distribute the Product into the commercial channel for the purpose of fulfilling the Product prescription demand and subsequent dispensing, the Company has agreed to make a second $3,000,000 payment (the &#8220;Second Payment&#8221;). The Second Payment may be increased to $5,000,000 if first year Product net sales meet or exceed $35 million. Additionally, the Company has agreed to pay Fabre-Kramer certain milestone payments ranging from $5,000,000 to over $100,000,000 per year based on sales milestones after a certain level of net sales are achieved with a threshold of $100,000,000 in net sales and the Company will pay 10% of net sales exceeding $1 billion. The Company has also agreed to pay royalty fees throughout the term of the Agreement based on the Company&#8217;s net sales of the Product as follows: (i) initially 28% of net sales and increasing to 39% if net sales exceed $300 million in any year during the Term until such net sales reach a reduced royalty trigger; and (ii) after reaching such royalty trigger, 24.5% and increasing to 35.5% if net sales exceed $300 million in any year during the Term. The Company will also pay a supply price of 3% of net sales less its cost of goods sold, increasing to 4% of net sales if annual net sales exceed $300 million. The Agreement also contains customary clauses for pharmaceutical commercialization agreements, including, among others, post-marketing trials and obligations, regulatory matters, and indemnification.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">The Agreement can be terminated at any time upon mutual agreement between the Company and Fabre-Kramer. Either party can terminate the Agreement at any time upon written notice for a material default or breach if the material default or breach is not cured within (1) ninety (90) days after written notice or (2) in the case of a breach that cannot be cured within ninety (90) days, within a reasonable period not exceeding one hundred and twenty (120) days after written notice. Additionally, either party can terminate the Agreement at any time upon writing notice if (1) either party withdraws the Product from the market in the Territory for safety reasons or (2)(i) the FDA materially restricts the indications for the Product, or (ii) federal or state pricing controls are imposed that would result in obvious or substantial loss of sales for the Product.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Agreement. The foregoing description of the terms of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which will be filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ending June 30, 2025, with confidential portions redacted.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Item 2.01 Completion of Acquisition or Disposition of Assets.</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Item 7.01 Regulation FD Disclosure.</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">On June 6, 2025, the Company issued a press release announcing the Agreement.&#160;A copy of the press release is attached as Exhibit 99.1 and incorporated herein by reference.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">The information in the press release attached as Exhibit 99.1 hereto shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 3pt; text-indent: 33pt; text-align: justify;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Item 9.01 Financial Statements and Exhibits.</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>(d) Exhibits.</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="nowrap: true; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; padding: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Exhibit Number</b></div>
			</td>
			<td style="vertical-align: top; width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 88%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Exhibit Description</b></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">99.1</div>
			</td>
			<td style="vertical-align: top; width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 88%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="ex_823251.htm" style="-sec-extract:exhibit;">Press Release dated June 6,&#160;2025</a></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">104</div>
			</td>
			<td style="vertical-align: top; width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 88%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SIGNATURES</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif;">
			<td style="vertical-align: top; width: 54%; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</td>
			<td colspan="2" style="vertical-align: top; width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">AYTU BIOPHARMA,&#160;INC.</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif;">
			<td style="vertical-align: top; width: 54%; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</td>
			<td colspan="2" style="vertical-align: top; width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif;">
			<td style="vertical-align: top; width: 54%; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</td>
			<td colspan="2" style="vertical-align: top; width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif;">
			<td style="vertical-align: top; width: 54%; font-family: &quot;Times New Roman&quot;, Times, serif;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Date: June 6, 2025</div>
			</td>
			<td style="vertical-align: top; width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">By:</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 43%; font-family: &quot;Times New Roman&quot;, Times, serif;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">/s/ Ryan J. Selhorn</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif;">
			<td style="vertical-align: top; width: 54%; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</td>
			<td style="vertical-align: top; width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</td>
			<td style="vertical-align: top; width: 43%; font-family: &quot;Times New Roman&quot;, Times, serif;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Ryan J. Selhorn</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif;">
			<td style="vertical-align: top; width: 54%; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</td>
			<td style="vertical-align: top; width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</td>
			<td style="vertical-align: top; width: 43%; font-family: &quot;Times New Roman&quot;, Times, serif;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Chief Financial Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_823251.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_823251.htm</title>
	<!-- Generated by ThunderDome Portal - 6/6/2025 2:38:30 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Exhibit 99.1</b></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<div><img alt="logo01.jpg" src="logo01.jpg"></div>
</div>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 14pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 14pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Aytu BioPharma&nbsp;Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA&#8482; (gepirone) Extended-Release Tablets in the United States</b></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><i>Aytu enters the over $22 billion United States prescription major depressive disorder (&#8220;MDD&#8221;) market with the first-in-class&nbsp;oral selective serotonin 5HT1a receptor agonist for adults with MDD.</i></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><i>EXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving more than 5,000 patients and, notably, the incidence of sexual side effects experienced with EXXUA was comparable to placebo.</i></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><i>EXXUA is expected to serve as a major growth catalyst as Aytu continues to build value for shareholders; the Company anticipates launching EXXUA in the fourth calendar quarter of 2025 as a centerpiece of its commercial efforts.</i></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><i>EXXUA transaction financed by long-term, healthcare-focused institutional investors, including Aytu&#8217;s largest shareholder Nantahala Capital Management, Stonepine Capital Management, Aytu management, and new institutional shareholders.</i></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>DENVER, CO / June 6</b><b>, 2025</b> / Aytu BioPharma,&nbsp;Inc. (the &#8220;Company&#8221; or &#8220;Aytu&#8221;) (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, announced the signing of an exclusive agreement to commercialize EXXUA&#8482; (gepirone) extended-release tablets (&#8220;EXXUA&#8221;) in the United States. Gepirone is a new chemical entity, and EXXUA is the first-in-class&nbsp;selective serotonin 5HT1a receptor agonist approved by the United States Food and Drug Administration (&#8220;FDA&#8221;) for the treatment of MDD in adults.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">EXXUA has been extensively studied in over 5,000 patients and represents a new class of therapeutics to compete in the over $22 billion United States prescription MDD market. Importantly, EXXUA is the only antidepressant acting on serotonin receptors that does not carry label warnings about the risk of sexual dysfunction. The mechanism of the antidepressant effect of EXXUA is believed to be related to its modulation of serotonin activity and, specifically, its exclusive and strong binding affinity for 5HT1a receptors, which are key regulators of mood and emotion. EXXUA is not a selective serotonin reuptake inhibitor (&#8220;SSRI&#8221;) and has no reuptake inhibition activity. EXXUA also exhibits no significant adverse effects on weight, blood pressure, heart rate or liver function.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Dr. Stephen Stahl, Professor of Psychiatry, University of California and founder of the Neuroscience Education Institute, a recognized expert neuropsychopharmacologist said &#8220;EXXUA is the first truly selective agonist of the serotonin 1a receptor that has been consistently linked to mediation of mood disorders and suicide risk. It&#8217;s an important addition to the armamentarium to treat depression.&#8221;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Josh Disbrow, Chief Executive Officer of Aytu, stated, &#8220;We are thrilled to be the exclusive commercialization partner for EXXUA in the United States and to be partnering with Fabre-Kramer Pharmaceuticals on this exciting opportunity. We believe that the licensing of EXXUA represents a transformative milestone for Aytu and a significant advancement for patients suffering from major depressive disorder.&#8221;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8220;Over the past two years, Aytu has undergone a planned, strategic pivot to focus on our core prescription business while seeking to acquire differentiated, branded CNS products that complement our portfolio and focus. We believe that EXXUA is a perfect strategic fit and will be a centerpiece of Aytu&#8217;s commercial efforts going forward considering the significant commercial potential, uniqueness of the product, our sales force&#8217;s CNS focus and alignment with our proprietary Aytu RxConnect patient access platform,&#8221; Disbrow continued.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8220;More importantly, given the compelling and novel product profile of EXXUA and the unmet needs of MDD patients, we believe EXXUA can become a very important treatment option for the over 21 million Americans affected by MDD. Over 340 million antidepressant prescriptions were written in 2024 in the United States, yet significant unmet needs remain considering the unacceptable side effects associated with current therapeutics. Aytu is well positioned to realize the significant market potential of EXXUA while positively impacting the lives of MDD patients. We look forward to launching EXXUA later this year and to our exciting partnership with Fabre-Kramer Pharmaceuticals,&#8221; Disbrow concluded.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Stephen Kramer, M.D., Co-Founder and Chief Executive Officer of Fabre-Kramer Pharmaceuticals said, &#8220;We are very pleased to be partnering with Aytu to bring EXXUA to the United States market. We developed EXXUA to address important unmet needs that I witnessed first-hand managing MDD patients for decades as a practicing psychiatrist. While therapeutic advancements have been made, issues such as treatment emergent sexual dysfunction and weight gain persist as problematic side effects of many MDD treatments. We believe EXXUA will be a very important addition to physicians managing the millions of patients with depression in the United States and worldwide.&#8221;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Under the terms of the agreement, upon closing Aytu paid Fabre-Kramer Pharmaceuticals an upfront payment and will pay an additional fixed payment at the one-year anniversary of the EXXUA launch date.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">In addition, Aytu will pay royalties on net revenue as defined in the definitive agreement, along with a product transfer price. Aytu will also make variable, performance-based milestone payments to Fabre-Kramer Pharmaceuticals upon the achievement of various net revenue thresholds over the term of the agreement.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">The EXXUA transaction is being funded by cash on hand along with a financing led by long-term, healthcare-focused institutional investors, including Aytu&#8217;s largest shareholder Nantahala Capital Management, Stonepine Capital Management, Aytu management, and new institutional shareholders.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Aytu is actively preparing to launch EXXUA in the United States as soon as possible and currently anticipates pharmacy and patient availability in the fourth calendar quarter of 2025. For more information and updates, please visit aytubio.com.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>About Aytu BioPharma</b></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Aytu is a pharmaceutical company focused on commercializing novel therapeutics. The Company&#8217;s prescription products include EXXUA&#8482; (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD), Adzenys XR-ODT&#174; (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT&#174; (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of attention deficit hyperactivity disorder (ADHD), and a line of legacy products, including Karbinal&#174; ER (carbinoxamine maleate), Poly-Vi-Flor&#174; and Tri-Vi-Flor&#174;. To learn more, please visit aytubio.com.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>About EXXUA</b></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">EXXUA is a novel oral selective serotonin 5HT1a receptor agonist indicated for the treatment of major depressive disorder (MDD) in adults. EXXUA is also being developed for other psychiatric disorders.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>INDICATIONS and IMPORTANT SAFETY INFORMATION for EXXUA</b></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i>INDICATIONS</i></b></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">EXXUA is indicated for the treatment of major depressive disorder (MDD) in adults.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i>IMPORTANT SAFETY INFORMATION</i></b></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">EXXUA is not approved for use in pediatric patients.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Do not take EXXUA if you:</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tr style="font-family: Arial, Helvetica, sans-serif;">
			<td style="vertical-align: middle; width: 8.6%; font-family: Arial, Helvetica, sans-serif;">&nbsp;</td>
			<td style="vertical-align: top; width: 4%; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">are allergic to EXXUA or any of the ingredients in EXXUA.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tr style="font-family: Arial, Helvetica, sans-serif;">
			<td style="vertical-align: middle; width: 8.6%; font-family: Arial, Helvetica, sans-serif;">&nbsp;</td>
			<td style="vertical-align: top; width: 4%; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">have a prolonged QTc interval greater than 450 msec or congenital long QT syndrome.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tr style="font-family: Arial, Helvetica, sans-serif;">
			<td style="vertical-align: middle; width: 8.6%; font-family: Arial, Helvetica, sans-serif;">&nbsp;</td>
			<td style="vertical-align: top; width: 4%; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">are taking medicines known as strong CYP3A4 inhibitors. Ask your healthcare provider if you are not sure if you are taking one of these medicines.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tr style="font-family: Arial, Helvetica, sans-serif;">
			<td style="vertical-align: middle; width: 8.6%; font-family: Arial, Helvetica, sans-serif;">&nbsp;</td>
			<td style="vertical-align: top; width: 4%; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">have severe liver problems.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tr style="font-family: Arial, Helvetica, sans-serif;">
			<td style="vertical-align: middle; width: 8.6%; font-family: Arial, Helvetica, sans-serif;">&nbsp;</td>
			<td style="vertical-align: top; width: 4%; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: Arial, Helvetica, sans-serif;">
			<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">are taking, or have stopped taking within the last 14 days, a medicine called a monoamine oxidase inhibitor (MAOI), including the antibiotic linezolid or intravenous methylene blue. Ask your healthcare provider or pharmacist if you are not sure if you take an MAOI, including the antibiotic linezolid or intravenous methylene blue.</p>
			</td>
		</tr>

</table>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Do not start taking an MAOI for at least 14 days after you have stopped treatment with EXXUA.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">EXXUA may cause serious side effects, including:</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Changes in the electrical activity of your heart called QT prolongation. QT prolongation can cause irregular heartbeats that can be life-threatening. Your healthcare provider will check the electrical activity of your heart with a test called an electrocardiogram (ECG) and will also do blood tests to check your levels of body salts (electrolytes) before and during treatment with EXXUA. Your healthcare provider may check your electrolytes more often during treatment if you have heart failure, a slow heart rate, abnormal levels of electrolytes in your blood, or if you take other medications that can prolong the QT interval of your heartbeat.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">A potentially life-threatening problem called serotonin syndrome can happen when EXXUA is taken with certain other medicines.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Manic episodes may happen in people with bipolar disorder who take EXXUA.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Please read FULL PRESCRIBING INFORMATION for EXXUA.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Forward-Looking Statements</b></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (&#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;). All statements other than statements of historical facts contained in this press release, are forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;forecast,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;suggest,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; or similar words, or the negatives of such terms or other variations on such terms or comparable terminology. All statements other than statements of historical facts contained in this press release, are forward-looking statements. These statements are predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others, risks associated with: the Company&#8217;s overall financial and operational performance, potential adverse changes to the Company&#8217;s financial position or our business, the results of operations, strategy and plans, changes in capital markets and the ability of the Company to finance operations in the manner expected, risks relating to gaining market acceptance of our products, our partners performing their required activities, our anticipated future cash position, regulatory and compliance challenges and future events under current and potential future collaborations. We also refer you to (i) the risks described in &#8220;Risk Factors&#8221; in Part I, Item 1A of our most recent Annual Report on Form 10&#8209;K and in the other reports and documents we file with the United States Securities and Exchange Commission.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Contacts for Investors</b></p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Ryan Selhorn, Chief Financial Officer</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Aytu BioPharma,&nbsp;Inc.</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">rselhorn@aytubio.com</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Robert Blum or Roger Weiss</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Lytham Partners</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">aytu@lythampartners.com</p>

<p style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>aytu-20250605.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/6/2025 7:45:55 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:aytu="http://www.aytu.com/20250605" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.aytu.com/20250605">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/cyd-8k-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aytu-20250605_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aytu-20250605_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aytu-20250605_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.aytu.com/20250605/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="aytu_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>aytu-20250605_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/6/2025 7:45:55 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.aytu.com/20250605/role/statement-document-and-entity-information" xlink:href="aytu-20250605.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.aytu.com/20250605/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>aytu-20250605_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/6/2025 7:45:55 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>aytu-20250605_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/6/2025 7:45:55 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.aytu.com/20250605/role/statement-document-and-entity-information" xlink:href="aytu-20250605.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.aytu.com/20250605/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  J )8# 2(  A$! Q$!_\0
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M-&R. RL-I!Z$&ORUUG]C[]H+]EWXU:MXG^""+K&CWYD6)X)( 1 [A_L\\$K
M':V,,OIGY<D4 ?J;(/D('I7Y7_\ !)2XCT[XU_$73+EA#?-I_$+<-\EP0_Y%
MA7U'^R1I/[2EUXTUKQ!\:;^T@T2YLA;VNBJT6^&8.")%2(%5!7>"2Q)ROI7A
MW[07[#/Q0^'_ ,:I_BI\ KW;>7<\EW+I\4\<$]M-(?WJIYA\N6)\DE6QCG@\
M8 /T@SQFOR2^*OB/3/%'_!5/PW=Z5=Q7UK%XBTFU>:%MRB6/RU=<]\-D?4&O
M4;71_P!N?XQ >'M9N[3P%I-P/+N=65;:&14/#8\IFD)QV7;GU%9OAG_@G#XS
M^&O[4'@GQ#X=-IJ'@K1+_3[NYU&[O ES</&0UQ)Y7."6W8 /I]: /TOHI-U%
M &)XI\,V'C'P[J&BZI;BYL+Z%H)HG'56&./0CJ#U! -?G]X.^&-]\,O'WBO1
MM2!::R*113$8$L3$LKCV(4?B#7Z,UXU\7])L;CQ3#-+9V\DK6L:F1XE+$!WP
M,XZ<G\Z^?XAK3CE&(IQ=D[?FCS*^!HU\51Q$E[T&[?<>#M]VL/58LJU>OMHN
MG_\ /C;?]^5_PJAJ&B:<0?\ 0+7K_P \5_PK\#PU!J=^8]RK\)XI\._A-+\4
M/B_9Z>Z$Z5&BW=^^./+4D;/JQ4#Z$U^AMG9QV5M#!$@CBB0(J*,!0!@ 5Y/\
M =)L;&'69+:SM[>1VB#-%$JEA\W!('/4UZ^>E?NO#^'A2P:FMY;G=C\PK8NG
M0HU'[L(I(DHI!TI:^G/("BBB@#Y+_;<_9A^(_P"U#/X;T/0O$6C:'X-L)/M%
MY#>/,9IYR<;]JH00B;MH+#)8YQP:]HN-'L_@)\$HM)\*VT<%KH-E%:V<;QM(
M/O*I8J""[$L6(!R2?>O3*X?XUJ&^%WB'(!_<*>?]]: .(A^->K:7:WKZE MP
M-/N&,I:QDLYI8193W'$,C$J=T.T-D@\U;\6?$/Q7X$THW&J3Z1>/>V,\]M]E
MA?\ T::- ^&&\^;'MW?.-OS!1_%QS'P<MH=1T[1;FZB2YN)]7"RS3*'>0"RN
M0 Q/)')Z^IK \#VL,NC>/U>&-UM89+6W#*"(8?.'[M/[J<#Y1QP*JP'H&E_&
M+5;37K:SU"V.K:7).\2:GIFFS@W&(=Y"0G<WR-PS#*G<.A!IFL?'B32/#NC:
MA)':K)//<3W45R3 XLX9C&Q5&.?-P5.T]=K<>GH'B"-3XW\),5!96O,$CD?N
MJY3X=Z793>*_$?F6<#XM$7YHE/!O+_(Z5(%'4?BSJT/CZ]TNRFL[N*/5;>PM
MM-6RE:2YB>VMYI)1<!MBE1,[8(Z1^^:J:#\<-9U5/#MK-HZ6VH76H0Q7DS!O
M(-K*Y6.2(]V;I@GY2C]>"<_PO:P_\*SU)_)CWQZSI,B-M&586NGJ&![';QGT
MXK=URWBC^#_AH+$BA+BW* *!M(+8QZ4 :W@#XO0>,?%&L:<;BS-NNZ?3V@D!
M=H4D\I_,&3@[P&'3Y9%HKE_BUI]KI_@+PH]K;0VSJBQJT,80A?*7Y1CM\J\>
&P]** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">AYTU BIOPHARMA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Jun.  05,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-38247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">47-0883144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">7900 East Union Avenue, Suite 920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Denver<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">80237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">437-6580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AYTU<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001385818<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="aytu20250523c_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aytu.com/20250605/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>aytu-20250605.xsd</File>
    <File>aytu-20250605_def.xml</File>
    <File>aytu-20250605_lab.xml</File>
    <File>aytu-20250605_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="aytu20250523c_8k.htm">aytu20250523c_8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>logo01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "aytu20250523c_8k.htm": {
   "nsprefix": "aytu",
   "nsuri": "http://www.aytu.com/20250605",
   "dts": {
    "schema": {
     "local": [
      "aytu-20250605.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-cr-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "aytu-20250605_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "aytu-20250605_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aytu-20250605_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "aytu20250523c_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 36,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.aytu.com/20250605/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aytu20250523c_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aytu20250523c_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Axis]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentDomain",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Domain]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r8"
     ]
    },
    "cyd_MaterialCybersecurityIncidentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Table]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.aytu.com/20250605/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001437749-25-019718-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-25-019718-xbrl.zip
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M#P6J^0@98YF@'8LQ1M$MH;U>*LT .R'8PR0&&[/UA@33N:DW:!P,'B.!D#K
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MT\IRV)V6N1(BX _'G8F9!KO_#U!+ P04    " #@@,9:CM]@WD\5  !S:P
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MU]?A[FJ-OIR093K";&NHX6+$K-=E DV&J1!F!B9?-<1U/!%J-@/KG5!7%6A
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M:$S*0^[;!DJ8%IH:P8^3@L>5'>YWZR([3=W45LF:*0C: B'1@CUH6EL-K>G
MSU2ITHL'R59.43UL&IL]CWRO0Q>PB8"0_]/+ 4<CH&5?G(-T5JI64: ^!$H3
M6SQ 7A-'1459CK(FN#20+U/FWL'VPB"R\*0V94^^HF11*UF+U& X #!X7&OA
M .04NG@I+>D;%C4U3<W=6^W.>X@L7;@9])/FMR;.\+Y0">"==D58_/)4/'JC
ME^VL,9)6%QYY3#&"RF7 (>30"P,Q] +,P\;YTYHNH&(>.CJ %P:I.1%$,SQL
MK0,8!"6 2P.52W9/<@9O1XU)_H>:!J-SF>DD$W >XEPM\&).$R!*80)%U#!
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MUC.:"O!(_P102P$"% ,4    " #@@,9: OL%U7T#   8#@  $0
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M  !S:P  #0              @ 'W*@  97A?.#(S,C4Q+FAT;5!+ 0(4 Q0
M   ( ." QEIK\'-^J T  $,.   *              "  7%   !L;V=O,#$N
9:G!G4$L%!@     '  < O0$  $%.      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>aytu20250523c_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aytu-20250605.xsd" xlink:type="simple"/>
    <context id="d20258K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001385818</identifier>
        </entity>
        <period>
            <startDate>2025-06-05</startDate>
            <endDate>2025-06-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20258K" id="ixv-252">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20258K" id="ixv-253">0001385818</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20258K" id="ixv-263">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20258K" id="ixv-264">2025-06-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20258K" id="ixv-265">AYTU BIOPHARMA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20258K" id="ixv-266">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20258K" id="ixv-267">001-38247</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20258K" id="ixv-268">47-0883144</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20258K" id="ixv-269">7900 East Union Avenue, Suite 920</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20258K" id="ixv-270">Denver</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20258K" id="ixv-271">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20258K" id="ixv-272">80237</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20258K" id="ixv-273">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20258K" id="ixv-274">437-6580</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20258K" id="ixv-275">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20258K" id="ixv-276">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20258K" id="ixv-277">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20258K" id="ixv-278">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20258K" id="ixv-279">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20258K" id="ixv-280">AYTU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20258K" id="ixv-281">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20258K" id="ixv-282">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
